Technical Specifications
Engineered to leverage the body's natural regenerative capabilities
100% Autologous
20ml of patient's peripheral blood (whole blood). No additives or synthetic compounds required.
20 minutes
Total procedure time from blood draw to application.
35%
Increase in re-epithelialization speed vs
standard of care.
4 Steps. 20 minutes. Applied
FastSkin® Patch was designed to fit into a 20-minute consultation without compromising care quality.
1
Collection
Drawing patient blood using the provided sterile kit.
2
Processing
Blood processing and coagulation in <10 min; no capital equipment required.
3
Transfer
Transfering the patch to the wound
4
Cover
Applying non-adherent dressing per standard of care.
Intended Use
The FastSkin® Patch is intended to be used at the point of care for the safe and rapid preparation of Whole Blood Clots (WBC) from a small sample of a patient’s own peripheral blood. Under the supervision of a healthcare professional, the WBC produced by the FastSkin® Patch is topically applied for the management of exuding cutaneous wounds, such as leg ulcers, pressure ulcers, diabetic ulcers, and mechanically or surgically debrided wounds.
Venous Leg Ulcers (VLU)
Diabetic Foot Ulcers (DFU)
Pressure Ulcers
Surgically Debrided Wounds
Traumatic Wounds
EARLY ACCESS
Secure Your FastSkin® Patch Kit
Be among the first institutions to offer the next generation of autologous wound care. Limited availability for the initial rollout.
No payment required at this stage. Non-binding inquiry